In melanoma study, CD31 and CD34 expression have been shown to be related to trans-differentiation of melanoma cells, thus implying that immunoreactivity for CD31 and CD34 is closely parallel with tumor progression and aggressive behavior of tumor cells16. The gene discussed is PECAM1; the disease is melanoma.